GL1X · GenesisL1 explorer

Research workbench

Human cytomegalovirus protease mutant (C84A, C87A, C138A, C202A) in complex with inhibitor

Analyse Human cytomegalovirus protease mutant (C84A, C87A, C138A, C202A) in complex… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7TCZ
Type
protein
Length
213 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Assemblin
EC
3.4.21.97
UniProt
A0A126N917
Ligands
GIT
Pockets
1 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAssemblin (EC 3.4.21.97)protein21335% helix, 23% strandA0A126N917

Ligands and binding sites

  • GIT · [1-(2-oxopropyl)-4-phenyl-1H-1,2,3-triazol-5-yl]methyl benzylcarbamate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11550.440.7523empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7TCZ · Human cytomegalovirus protease mutant (C84A, C87A, C138A, C202A) in complex with inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.